{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:49:35Z","timestamp":1792028975095,"version":"4.4.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2018-12367747"],"award-info":[{"award-number":["GR-2018-12367747"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente and 5x1000 funds"],"award-info":[{"award-number":["Ricerca Corrente and 5x1000 funds"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana Ricerca sul Cancro","doi-asserted-by":"crossref","award":["IG 2023 ID 28890"],"award-info":[{"award-number":["IG 2023 ID 28890"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","award":["Fellowship"],"award-info":[{"award-number":["Fellowship"]}],"id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Melanoma exhibits high intratumoral heterogeneity, characterized by a diverse population of cells undergoing dynamic transitions between cellular states. These adaptive changes enable melanoma cells to survive in the harsh tumor microenvironment, acquire drug resistance, and metastasize. One such state, quiescence, has been linked to both relapse and drug resistance, but its underlying biology and molecular mechanisms remain poorly understood. Our study challenges the conventional understanding of melanoma quiescence. Contrary to the notion of a rare, unique subpopulation, we demonstrate that quiescence is a highly dynamic state accessible to most, if not all, melanoma cells. This state is exquisitely sensitive to microenvironmental cues. We identify GPNMB as a marker of quiescence, that is expressed in both primary and metastatic tumors. GPNMB-positive cells exhibit a pro-metastatic phenotype and are enriched in metastatic sites, suggesting a potential role for quiescence in tumor dissemination. Our findings position GPNMB as a valuable marker for isolating quiescent melanoma cells and as a potential therapeutic target to tackle metastasis.<\/jats:p>","DOI":"10.1038\/s44319-025-00501-w","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:06:04Z","timestamp":1750136764000},"page":"3804-3830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["GPNMB marks a\u00a0quiescent cell population in melanoma and promotes metastasis formation"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4897-0420","authenticated-orcid":false,"given":"Fiorenza","family":"Lotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-8262","authenticated-orcid":false,"given":"Marine","family":"Melixetian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5264-3591","authenticated-orcid":false,"given":"Thalia","family":"Vlachou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-7203","authenticated-orcid":false,"given":"Marco S","family":"Nobile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leone","family":"Bacciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-1593","authenticated-orcid":false,"given":"Marco","family":"Malferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0224-073X","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Quaresima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Rapino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-5499","authenticated-orcid":false,"given":"Federica","family":"Marocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-4804","authenticated-orcid":false,"given":"Massimo","family":"Barberis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-6597","authenticated-orcid":false,"given":"Chiara","family":"Soriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velia","family":"Mollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ferrarotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6255-5851","authenticated-orcid":false,"given":"Pier Francesco","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5076-2316","authenticated-orcid":false,"given":"Pier Giuseppe","family":"Pelicci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-4179","authenticated-orcid":false,"given":"Lucilla","family":"Luzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-3815","authenticated-orcid":false,"given":"Luisa","family":"Lanfrancone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"501_CR1","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1158\/1535-7163.MCT-16-0535","volume":"16","author":"A Ahn","year":"2017","unstructured":"Ahn A, Chatterjee A, Eccles MR (2017) The slow cycling phenotype: a growing problem for treatment resistance in melanoma. Mol Cancer Ther 16:1002\u20131009","journal-title":"Mol Cancer Ther"},{"key":"501_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22063102","volume":"22","author":"N Alessio","year":"2021","unstructured":"Alessio N, Aprile D, Cappabianca S, Peluso G, Di Bernardo G, Galderisi U (2021) Different stages of quiescence, senescence, and cell stress identified by molecular algorithm based on the expression of ki67, rps6, and beta-galactosidase activity. Int J Mol Sci 22:1\u201313","journal-title":"Int J Mol Sci"},{"key":"501_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W (2015) HTSeq-A Python framework to work with high-throughput sequencing data. Bioinformatics 31:166\u2013169","journal-title":"Bioinformatics"},{"key":"501_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-32448-0","volume":"13","author":"F Antonica","year":"2022","unstructured":"Antonica F, Santomaso L, Pernici D, Petrucci L, Aiello G, Cutarelli A, Conti L, Romanel A, Miele E, Tebaldi T et al (2022) A slow-cycling\/quiescent cells subpopulation is involved in glioma invasiveness. Nat Commun 13:1\u201315","journal-title":"Nat Commun"},{"key":"501_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/jcp.25900","volume":"233","author":"OA Arosarena","year":"2018","unstructured":"Arosarena OA, Barr EW, Thorpe R, Yankey H, Tarr JT, Safadi FF (2018) Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases. J Cell Physiol 233:409\u2013421","journal-title":"J Cell Physiol"},{"key":"501_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41568-019-0154-4","volume":"19","author":"I Arozarena","year":"2019","unstructured":"Arozarena I, Wellbrock C (2019) Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat Rev Cancer 19:377\u2013391","journal-title":"Nat Rev Cancer"},{"key":"501_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.00722","volume":"10","author":"A Avagliano","year":"2020","unstructured":"Avagliano A, Fiume G, Pelagalli A, Sanit\u00e0 G, Ruocco MR, Montagnani S, Arcucci A (2020) Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front Oncol 10:1\u201321","journal-title":"Front Oncol"},{"key":"501_CR8","doi-asserted-by":"crossref","unstructured":"Bailey Kate M, Wojtkowiak J, Hashim Arig Ibrahim GRJ (2012) Targeting the metabolic microenvironment of tumors. Adv Pharmacol 65:63\u2013107","DOI":"10.1016\/B978-0-12-397927-8.00004-X"},{"key":"501_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:1\u20137","journal-title":"Sci Rep"},{"key":"501_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.semcancer.2021.04.021","volume":"78","author":"S Basu","year":"2022","unstructured":"Basu S, Dong Y, Kumar R, Jeter C, Tang DG (2022) Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis. Semin Cancer Biol 78:90\u2013103","journal-title":"Semin Cancer Biol"},{"key":"501_CR11","unstructured":"Becconi M, Malferrari M, Lesch A, Salvatore D, Zironi I, Conte M, Simonetti G, Pelicci PG, Girault HH, Salvioli S, Castellani G, Zerbetto FRS Microfabrication of cell culturing microenvironments with spatially controlled oxygen levels."},{"key":"501_CR12","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","volume":"16","author":"S Berg","year":"2019","unstructured":"Berg S, Kutra D, Kroeger T, Straehle CN, Kausler BX, Haubold C, Schiegg M, Ales J, Beier T, Rudy M et al (2019) Ilastik: Interactive machine learning for (bio)image analysis. Nat Methods 16:1226\u20131232","journal-title":"Nat Methods"},{"key":"501_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nrc2540","volume":"8","author":"JA Bertout","year":"2008","unstructured":"Bertout JA, Patel SA, Simon MC (2008) Bertout, 2008, impact of oxygen reduction. Nat Rev Cancer 8:967\u2013975","journal-title":"Nat Rev Cancer"},{"key":"501_CR14","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","volume":"32","author":"SN Bhatia","year":"2014","unstructured":"Bhatia SN, Ingber DE (2014) Microfluidic organs-on-chips. Nat Biotechnol 32:760\u2013772","journal-title":"Nat Biotechnol"},{"key":"501_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nature09161","volume":"466","author":"AD Boiko","year":"2010","unstructured":"Boiko AD, Razorenova OV, Van De Rijn M, Swetter SM, Johnson DL, Ly DP, Butler PD, Yang GP, Joshua B, Kaplan MJ et al (2010) Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 466:133\u2013137","journal-title":"Nature"},{"key":"501_CR16","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/2159-8290.CD-15-1200","volume":"6","author":"D Bossi","year":"2016","unstructured":"Bossi D, Cicalese A, Dellino GI, Luzi L, Riva L, D\u2019Alesio C, Diaferia GR, Carugo A, Cavallaro E, Piccioni R et al (2016) In Vivo genetic screens of patient-derived tumors revealed unexpected frailty of the transformed phenotype. Cancer Discov 6:650\u2013663","journal-title":"Cancer Discov"},{"key":"501_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fonc.2020.00476","volume":"10","author":"RAM Brown","year":"2020","unstructured":"Brown RAM, Richardson KL, Kabir TD, Trinder D, Ganss R, Leedman PJ (2020) Altered iron metabolism and impact in cancer biology, metastasis, and immunology. Front Oncol 10:476","journal-title":"Front Oncol"},{"key":"501_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-28801-y","volume":"13","author":"C Capparelli","year":"2022","unstructured":"Capparelli C, Purwin TJ, Glasheen MK, Caksa S, Tiago M, Wilski N, Pomante D, Rosenbaum S, Nguyen MQ, Cai W et al (2022) Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma. Nat Commun 13:1\u201316","journal-title":"Nat Commun"},{"key":"501_CR19","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/onc.2011.425","volume":"31","author":"Y Cheli","year":"2012","unstructured":"Cheli Y, Giuliano S, Fenouille N, Allegra M, Hofman V, Hofman P, Bahadoran P, Lacour JP, Tartare-Deckert S, Bertolotto C et al (2012) Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31:2461\u20132470","journal-title":"Oncogene"},{"key":"501_CR20","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1158\/0008-5472.CAN-18-0599","volume":"78","author":"C Chen","year":"2018","unstructured":"Chen C, Okita Y, Watanabe Y, Abe F, Fikry MA, Ichikawa Y, Suzuki H, Shibuya A, Kato M (2018) Glycoprotein nmb is exposed on the surface of dormant breast cancer cells and induces stem cell-like properties. Cancer Res 78:6424\u20136435","journal-title":"Cancer Res"},{"key":"501_CR21","first-page":"1","volume":"7","author":"J Chen","year":"2012","unstructured":"Chen J, Wang M, Xi B, Xue J, He D, Zhang J, Zhao Y (2012) SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer. PLoS ONE 7:1\u201315","journal-title":"PLoS ONE"},{"key":"501_CR22","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-10-3997","volume":"71","author":"G Civenni","year":"2011","unstructured":"Civenni G, Walter A, Kobert N, Mihic-Probst D, Zipser M, Belloni B, Seifert B, Moch H, Dummer R, Van Den Broek M et al (2011) Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 71:3098\u20133109","journal-title":"Cancer Res"},{"key":"501_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-3-030-22254-3_15","volume":"1164","author":"JE Davis Jr","year":"2019","unstructured":"Davis Jr JE, Kirk J, Ji Y, Tang DG (2019) Tumor dormancy and slow-cycling cancer cells. Adv Exp Med Biol 1164:199\u2013206","journal-title":"Adv Exp Med Biol"},{"key":"501_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41389-023-00452-8","volume":"12","author":"S Diazzi","year":"2023","unstructured":"Diazzi S, Tartare-Deckert S, Deckert M (2023) The mechanical phenotypic plasticity of melanoma cell: an emerging driver of therapy cross-resistance. Oncogenesis 12:1\u20137","journal-title":"Oncogenesis"},{"key":"501_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-020-01719-5","volume":"21","author":"A Emami Nejad","year":"2021","unstructured":"Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M et al (2021) The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int 21:1\u201326","journal-title":"Cancer Cell Int"},{"key":"501_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrd4539","volume":"14","author":"EW Esch","year":"2015","unstructured":"Esch EW, Bahinski A, Huh D (2015) Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov 14:248\u2013260","journal-title":"Nat Rev Drug Discov"},{"key":"501_CR27","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.yexcr.2010.02.015","volume":"316","author":"B Falkowska-Hansen","year":"2010","unstructured":"Falkowska-Hansen B, Kollar J, Gr\u00fcner BM, Schanz M, Boukamp P, Siveke J, Rethwilm A, Kirschner M (2010) An inducible Tet-Off-H2B-GFP lentiviral reporter vector for detection and in vivo isolation of label-retaining cells. Exp Cell Res 316:1885\u20131895","journal-title":"Exp Cell Res"},{"key":"501_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12113368","volume":"12","author":"L Fattore","year":"2020","unstructured":"Fattore L, Mancini R, Ciliberto G (2020) Cancer stem cells and the slow cycling phenotype: how to cut the Gordian knot driving resistance to therapy in melanoma. Cancers 12:1\u201321","journal-title":"Cancers"},{"key":"501_CR29","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3892\/ol.2020.11787","volume":"20","author":"X Feng","year":"2020","unstructured":"Feng X, Zhang L, Ke S, Liu T, Hao L, Zhao P, Tu W, Cang S (2020) High expression of GPNMB indicates an unfavorable prognosis in glioma: combination of data from the GEO and CGGA databases and validation in tissue microarray. Oncol Lett 20:2356\u20132368","journal-title":"Oncol Lett"},{"key":"501_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yexcr.2014.02.025","volume":"323","author":"C Fiorentini","year":"2014","unstructured":"Fiorentini C, Bodei S, Bedussi F, Fragni M, Bonini SA, Simeone C, Zani D, Berruti A, Missale C, Memo M et al (2014) GPNMB\/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity. Exp Cell Res 323:100\u2013111","journal-title":"Exp Cell Res"},{"key":"501_CR32","doi-asserted-by":"crossref","unstructured":"Grzywa TM, Paskal W, W\u0142odarski PK (2017) Intratumor and intertumor heterogeneity in melanoma. Transl Oncol 10:956\u2013975","DOI":"10.1016\/j.tranon.2017.09.007"},{"key":"501_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2021.778492","volume":"11","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W, Zheng L, Li X (2021) The role of iron in cancer progression. Front Oncol 11:1\u201318","journal-title":"Front Oncol"},{"key":"501_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinforma 14:7","journal-title":"BMC Bioinforma"},{"key":"501_CR35","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1093\/bioinformatics\/btz877","volume":"36","author":"R Hillje","year":"2020","unstructured":"Hillje R, Pelicci PG, Luzi L (2020) Cerebro: interactive visualization of scRNA-seq data. Bioinformatics 36:2311\u20132313","journal-title":"Bioinformatics"},{"key":"501_CR36","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek KS, Eichhoff OM, Schlegel NC, D\u00f6bbeling U, Kobert N, Schaerer L, Hemmi S, Dummer R (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68:650\u2013656","journal-title":"Cancer Res"},{"key":"501_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/j.1755-148X.2010.00757.x","volume":"23","author":"KS Hoek","year":"2010","unstructured":"Hoek KS, Goding CR (2010) Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res 23:746\u2013759","journal-title":"Pigment Cell Melanoma Res"},{"key":"501_CR38","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3390\/ijms24021601","volume":"24","author":"SM Hossain","year":"2023","unstructured":"Hossain SM, Eccles MR (2023) Phenotype switching and the melanoma microenvironment; impact on immunotherapy and drug resistance. Int J Mol Sci 24:1601","journal-title":"Int J Mol Sci"},{"key":"501_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-9-r183","volume":"8","author":"DW Huang","year":"2007","unstructured":"Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA (2007) The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 8:R183","journal-title":"Genome Biol"},{"key":"501_CR40","first-page":"1","volume":"11","author":"F Huang","year":"2021","unstructured":"Huang F, Santinon F, Flores Gonz\u00e1lez RE, del Rinc\u00f3n SV (2021a) Melanoma plasticity: promoter of metastasis and resistance to therapy. Front Oncol 11:1\u201321","journal-title":"Front Oncol"},{"key":"501_CR41","first-page":"1","volume":"11","author":"YH Huang","year":"2021","unstructured":"Huang YH, Chu PY, Chen JL, Huang CT, Huang CC, Tsai Y\u2010F, Wang YL, Lien PJ, Tseng LM, Liu CY (2021b) Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer. Sci Rep 11:1\u201312","journal-title":"Sci Rep"},{"key":"501_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14092104","volume":"14","author":"A Janowska","year":"2022","unstructured":"Janowska A, Iannone M, Fidanzi C, Romanelli M, Filippi L, Del Re M, Martins M, Dini V (2022) The genetic basis of dormancy and awakening in cutaneous metastatic melanoma. Cancers 14:1\u201315","journal-title":"Cancers"},{"key":"501_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20020273","volume":"20","author":"M Jung","year":"2019","unstructured":"Jung M, Mertens C, Tomat E, Br\u00fcne B (2019) Iron as a central player and promising target in cancer progression. Int J Mol Sci 20:1\u201318","journal-title":"Int J Mol Sci"},{"key":"501_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41586-022-05242-7","volume":"610","author":"P Karras","year":"2022","unstructured":"Karras P, Bordeu I, Pozniak J, Nowosad A, Pazzi C, Van Raemdonck N, Landeloos E, Van Herck Y, Pedri D, Bervoets G et al (2022) A cellular hierarchy in melanoma uncouples growth and metastasis. Nature 610:190\u2013198","journal-title":"Nature"},{"key":"501_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/cancers11020177","volume":"11","author":"Y Katsura","year":"2019","unstructured":"Katsura Y, Ohara T, Noma K, Ninomiya T, Kashima H, Kato T, Sato H, Komoto S, Narusaka T, Tomono Y et al (2019) A novel combination cancer therapy with iron chelator targeting cancer stem cells via suppressing stemness. Cancers 11:177","journal-title":"Cancers"},{"key":"501_CR47","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/j.jtho.2021.01.204","volume":"16","author":"S Khan","year":"2021","unstructured":"Khan S, Sun Z, Pillai R, Dahlberg S, Malhotra J, Keresztes R, Ikpeazu C, Ma P, Ramalingam S (2021) MA01.09 efficacy and safety of glembatumumab vedotin in patients with advanced or metastatic squamous cell carcinoma of the lung (PrECOG 0504). J Thorac Oncol 16:S131\u2013S132","journal-title":"J Thorac Oncol"},{"key":"501_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertion, deletions and gene fusion. Genome Biol 14:R36","journal-title":"Genome Biol"},{"key":"501_CR49","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1158\/1078-0432.CCR-05-2797","volume":"12","author":"CT Kuan","year":"2006","unstructured":"Kuan CT, Wakiya K, Dowell JM, Herndon JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD (2006) Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme. Clin Cancer Res 12:1970\u20131982","journal-title":"Clin Cancer Res"},{"key":"501_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41416-020-01159-y","volume":"124","author":"PR Kumar","year":"2021","unstructured":"Kumar PR, Moore JA, Bowles KM, Rushworth SA, Moncrieff MD (2021) Mitochondrial oxidative phosphorylation in cutaneous melanoma. Br J Cancer 124:115\u2013123","journal-title":"Br J Cancer"},{"key":"501_CR51","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.neo.2022.100865","volume":"36","author":"A Kusienicka","year":"2023","unstructured":"Kusienicka A, Cie\u015bla M, Bukowska-Strakova K, Nowak WN, Bronisz-Budzy\u0144ska I, Seretny A, \u017bukowska M, Je\u017c M, Wolnik J, J\u00f3zkowicz A (2023) Slow-cycling murine melanoma cells display plasticity and enhanced tumorigenicity in syngeneic transplantation assay. Neoplasia 36:100865","journal-title":"Neoplasia"},{"key":"501_CR108","doi-asserted-by":"crossref","unstructured":"La T, Chen S, Guo T, Zhao XH, Teng L, Li D, Carnell M, Zhang YY, Feng YC, Cole N et al (2021) Visualization of endogenous p27 and Ki67 reveals the importance of a c-Myc-driven metabolic switch in promoting survival of quiescent cancer cells. Theranostics 11:9605\u20139622","DOI":"10.7150\/thno.63763"},{"key":"501_CR52","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1038\/s41388-022-02443-2","volume":"41","author":"AM Lazaratos","year":"2022","unstructured":"Lazaratos AM, Annis MG, Siegel PM (2022) GPNMB: a potent inducer of immunosuppression in cancer. Oncogene 41:4573\u20134590","journal-title":"Oncogene"},{"key":"501_CR53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb3295","volume":"18","author":"A Lin","year":"2016","unstructured":"Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y et al (2016) The LINK-A lncRNA activates normoxic HIF1\u03b1 signalling in triple-negative breast cancer. Nat Cell Biol 18:213\u2013224","journal-title":"Nat Cell Biol"},{"key":"501_CR54","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.3390\/ijms24043762","volume":"24","author":"E Lindell","year":"2023","unstructured":"Lindell E, Zhong L, Zhang X (2023) Quiescent Cancer Cells\u2014a potential therapeutic target to overcome tumor resistance and relapse. Int J Mol Sci 24:3762","journal-title":"Int J Mol Sci"},{"key":"501_CR55","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/pcmr.12802","volume":"32","author":"P Louphrasitthiphol","year":"2019","unstructured":"Louphrasitthiphol P, Ledaki I, Chauhan J, Falletta P, Siddaway R, Buffa FM, Mole DR, Soga T, Goding CR (2019) MITF controls the TCA cycle to modulate the melanoma hypoxia response. Pigment Cell Melanoma Res 32:792\u2013808","journal-title":"Pigment Cell Melanoma Res"},{"key":"501_CR56","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1038\/jid.2012.161","volume":"132","author":"Y Luo","year":"2012","unstructured":"Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, Robinson SE, Liu W, Lewis KD, McCarter MD, Gonzalez R et al (2012) Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Investig Dermatol 132:2440\u20132450","journal-title":"J Investig Dermatol"},{"key":"501_CR57","first-page":"839","volume":"6","author":"G Maric","year":"2013","unstructured":"Maric G, Rose AAN, Annis MG, Siegel PM (2013) Glycoprotein non-metastatic b (GPNMB): a metastatic mediator and emerging therapeutic target in cancer. Onco Targets Ther 6:839\u2013852","journal-title":"Onco Targets Ther"},{"key":"501_CR58","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.celrep.2018.06.110","volume":"24","author":"I Miller","year":"2018","unstructured":"Miller I, Min M, Yang C, Tian C, Gookin S, Carter D, Spence SL (2018) Ki67 is a graded rather than a binary marker of proliferation versus quiescence graphical abstract HHS public access. Cell Rep 24:1105\u20131112","journal-title":"Cell Rep"},{"key":"501_CR59","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1089\/scd.2011.0477","volume":"21","author":"N Moore","year":"2012","unstructured":"Moore N, Houghton J, Lyle S (2012) Slow-cycling therapy-resistant cancer cells. Stem Cells Dev 21:1822\u20131830","journal-title":"Stem Cells Dev"},{"key":"501_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1005905","volume":"12","author":"MA Morrissey","year":"2016","unstructured":"Morrissey MA, Jayadev R, Miley GR, Blebea CA, Chi Q, Ihara S, Sherwood DR (2016) SPARC promotes cell invasion in vivo by decreasing type IV collagen levels in the basement membrane. PLoS Genet 12:1\u201324","journal-title":"PLoS Genet"},{"key":"501_CR61","doi-asserted-by":"crossref","unstructured":"Motwani J, Eccles MR (2021) Genetic and genomic pathways of melanoma development, invasion and metastasis. Genes 12:1543","DOI":"10.3390\/genes12101543"},{"key":"501_CR62","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/HP.S93413","volume":"3","author":"B Muz","year":"2015","unstructured":"Muz B, de la Puente P, Azab F, Azab AK (2015) The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia 3:83\u201392","journal-title":"Hypoxia"},{"key":"501_CR63","doi-asserted-by":"crossref","unstructured":"Nabil WNN, Xi Z, Song Z, Jin L, Zhang XD, Zhou H, De Souza P, Dong Q, Xu H (2021) Towards a framework for better understanding of quiescent cancer cells. Cells 10:1\u201319","DOI":"10.3390\/cells10030562"},{"key":"501_CR42","doi-asserted-by":"crossref","unstructured":"Nobile MS, Vlachou T, Spolaor S, Cazzaniga P, Mauri G, Pelicci PG, Besozzi D (2019) ProCell: Investigating cell proliferation with Swarm Intelligence. 16th IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), Certosa di Pontignano, Siena, Italy","DOI":"10.1109\/CIBCB.2019.8791468"},{"key":"501_CR64","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1093\/bioinformatics\/btz063","volume":"35","author":"MS Nobile","year":"2019","unstructured":"Nobile MS, Vlachou T, Spolaor S, Bossi D, Cazzaniga P, Lanfrancone L, Mauri G, Pelicci PG, Besozzi D (2019) Modeling cell proliferation in human acute myeloid leukemia xenografts. Bioinformatics 35:3378\u20133386","journal-title":"Bioinformatics"},{"key":"501_CR65","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/2159-8290.CD-13-0005","volume":"3","author":"MP O\u2019Connell","year":"2013","unstructured":"O\u2019Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, Li L, Herlyn M, Villanueva J, Liu Q et al (2013) Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov 3:1378\u20131393","journal-title":"Cancer Discov"},{"key":"501_CR66","doi-asserted-by":"publisher","first-page":"37289","DOI":"10.18632\/oncotarget.26472","volume":"9","author":"Y Okita","year":"2018","unstructured":"Okita Y, Chen C, Kato M (2018) Cell-surface GPNMB and induction of stemness. Oncotarget 9:37289\u201337290","journal-title":"Oncotarget"},{"key":"501_CR67","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/cncr.31892","volume":"125","author":"PA Ott","year":"2019","unstructured":"Ott PA, Pavlick AC, Johnson DB, Hart LL, Infante JR, Luke JJ, Lutzky J, Rothschild NE, Spitler LE, Cowey CL et al (2019) A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma. Cancer 125:1113\u20131123","journal-title":"Cancer"},{"key":"501_CR68","doi-asserted-by":"publisher","first-page":"13932","DOI":"10.18632\/oncotarget.7323","volume":"7","author":"MO Oyewumi","year":"2016","unstructured":"Oyewumi MO, Manickavasagam D, Novak K, Wehrung D, Paulic N, Moussa FM, Sondag GR, Safadi FF (2016) Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells. Oncotarget 7:13932\u201313944","journal-title":"Oncotarget"},{"key":"501_CR69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/cancers8030034","volume":"8","author":"G Parmiani","year":"2016","unstructured":"Parmiani G (2016) Melanoma cancer stem cells: markers and functions. Cancers 8:4\u20138","journal-title":"Cancers"},{"key":"501_CR70","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/onc.2017.341","volume":"37","author":"M Perego","year":"2018","unstructured":"Perego M, Maurer M, Wang JX, Shaffer S, M\u00fcller AC, Parapatics K, Li L, Hristova D, Shin S, Keeney F et al (2018) A slow-cycling subpopulation of melanoma cells with highly invasive properties. Oncogene 37:302\u2013312","journal-title":"Oncogene"},{"key":"501_CR71","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","volume":"187","author":"J Pozniak","year":"2024","unstructured":"Pozniak J, Pedri D, Landeloos E, Van Herck Y, Antoranz A, Vanwynsberghe L, Nowosad A, Roda N, Makhzami S, Bervoets G et al (2024) A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma. Cell 187:166\u2013183.e25","journal-title":"Cell"},{"key":"501_CR72","doi-asserted-by":"crossref","unstructured":"Prasmickaite L, Enges\u00e6ter B, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, M\u00e6landsmo GM (2010) Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS ONE 5:e10731","DOI":"10.1371\/journal.pone.0010731"},{"key":"501_CR73","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.1172\/JCI96393","volume":"128","author":"I Puig","year":"2018","unstructured":"Puig I, Tenbaum SP, Chicote I, Arqu\u00e9s O, Mart\u00ednez-Quintanilla J, Cuesta-Borr\u00e1s E, Ram\u00edrez L, Gonzalo P, Soto A, Aguilar S et al (2018) TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J Clin Investig 128:3887\u20133905","journal-title":"J Clin Investig"},{"key":"501_CR74","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.tips.2017.05.002","volume":"38","author":"GZ Qiu","year":"2017","unstructured":"Qiu GZ, Jin MZ, Dai JX, Sun W, Feng JH, Jin WL (2017) Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies. Trends Pharm Sci 38:669\u2013686","journal-title":"Trends Pharm Sci"},{"key":"501_CR75","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ccr.2010.10.012","volume":"18","author":"E Quintana","year":"2010","unstructured":"Quintana E, Shackleton M, Foster HR, Fullen DR, Sabel MS, Johnson TM, Morrison SJ (2010) Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18:510\u2013523","journal-title":"Cancer Cell"},{"key":"501_CR76","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41416-019-0651-y","volume":"122","author":"V Raimondi","year":"2020","unstructured":"Raimondi V, Ciccarese F, Ciminale V (2020) Oncogenic pathways and the electron transport chain: a dangeROS liaison. Br J Cancer 122:168\u2013181","journal-title":"Br J Cancer"},{"key":"501_CR77","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","volume":"33","author":"F Rambow","year":"2019","unstructured":"Rambow F, Marine JC, Goding CR (2019) Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev 33:1295\u20131318","journal-title":"Genes Dev"},{"key":"501_CR78","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","volume":"174","author":"F Rambow","year":"2018","unstructured":"Rambow F, Rogiers A, Marin-Bejar O, Aibar S, Femel J, Dewaele M, Karras P, Brown D, Chang YH, Debiec-Rychter M et al (2018) Toward minimal residual disease-directed therapy in melanoma. Cell 174:843\u2013855.e19","journal-title":"Cell"},{"key":"501_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-023-01129-w","volume":"21","author":"S Razi","year":"2023","unstructured":"Razi S, Haghparast A, Chodari Khameneh S, Ebrahimi Sadrabadi A, Aziziyan F, Bakhtiyari M, Nabi-Afjadi M, Tarhriz V, Jalili A, Zalpoor H (2023) The role of tumor microenvironment on cancer stem cell fate in solid tumors. Cell Commun Signal 21:1\u201323","journal-title":"Cell Commun Signal"},{"key":"501_CR80","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.cell.2010.04.020","volume":"141","author":"A Roesch","year":"2010","unstructured":"Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M (2010) A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141:583\u2013594","journal-title":"Cell"},{"key":"501_CR81","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D, K\u00f6rbel C, Laschke MW, Gimotty PA, Philipp SE et al (2013) Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1Bhigh cells. Cancer Cell 23:811\u2013825","journal-title":"Cancer Cell"},{"key":"501_CR82","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.05.010","volume":"179","author":"AAN Rose","year":"2017","unstructured":"Rose AAN, Biondini M, Curiel R, Siegel PM (2017) Targeting GPNMB with glembatumumab vedotin: current developments and future opportunities for the treatment of cancer. Pharm Ther 179:127\u2013141","journal-title":"Pharm Ther"},{"key":"501_CR83","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, Stang A, Roesch A, Ugurel S (2018) Melanoma. Lancet 392:971\u2013984","journal-title":"Lancet"},{"key":"501_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature06489","volume":"451","author":"T Schatton","year":"2008","unstructured":"Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C et al (2008) Identification of cells initiating human melanomas. Nature 451:345\u2013349","journal-title":"Nature"},{"key":"501_CR85","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2009","unstructured":"Schindelin J, Arganda-Carrera I, Frise E, Verena K, Mark L, Tobias P, Stephan P, Curtis R, Stephan S, Benjamin S et al (2009) Fiji\u2014an Open platform for biological image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"501_CR86","doi-asserted-by":"crossref","unstructured":"Schmidt U, Weigert M, Broaddus C, Myers G (2018) Cell detection with star-convex polygons. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) 11071 LNCS:265\u2013273","DOI":"10.1007\/978-3-030-00934-2_30"},{"key":"501_CR87","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1158\/0008-5472.CAN-20-0378","volume":"80","author":"D Shiokawa","year":"2021","unstructured":"Shiokawa D, Sakai H, Ohata H, Miyazaki T, Kanda Y, Sekine S, Narushima D, Hosokawa M, Kato M, Suzuki Y et al (2021) Slow-cycling cancer stem cells regulate progression and chemoresistance in colon cancer. Cancer Res 80:4451\u20134464","journal-title":"Cancer Res"},{"key":"501_CR88","doi-asserted-by":"publisher","first-page":"6486173","DOI":"10.1155\/2019\/6486173","volume":"2019","author":"CM Simbulan-Rosenthal","year":"2019","unstructured":"Simbulan-Rosenthal CM, Gaur A, Zhou H, Abdussamad M, Qin Q, Dougherty R, Aljehane L, Kuo LW, Vakili S, Karna K et al (2019) CD133 is associated with increased melanoma cell survival after multikinase inhibition. J Oncol 2019:6486173","journal-title":"J Oncol"},{"key":"501_CR89","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.3389\/fimmu.2020.02166","volume":"11","author":"A Sistigu","year":"2020","unstructured":"Sistigu A, Musella M, Galassi C, Vitale I, De Maria R (2020) Tuning cancer fate: tumor microenvironment\u2019s role in cancer stem cell quiescence and reawakening. Front Immunol 11:2166","journal-title":"Front Immunol"},{"key":"501_CR90","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R (2019) Comprehensive integration of single-cell data. Cell 177:1888\u20131902.e21","journal-title":"Cell"},{"key":"501_CR91","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545\u201315550","journal-title":"Proc Natl Acad Sci USA"},{"key":"501_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2023.1252567","volume":"14","author":"N Ta","year":"2023","unstructured":"Ta N, Jiang X, Zhang Y, Wang H (2023) Ferroptosis as a promising therapeutic strategy for melanoma. Front Pharm 14:1\u201311","journal-title":"Front Pharm"},{"key":"501_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.steroids.2017.10.013","volume":"133","author":"M Taya","year":"2018","unstructured":"Taya M, Hammes SR (2018) Glycoprotein non-metastatic melanoma protein B (GPNMB) and cancer: a novel potential therapeutic target. Steroids 133:102\u2013107","journal-title":"Steroids"},{"key":"501_CR94","doi-asserted-by":"publisher","first-page":"2087204","DOI":"10.1155\/2016\/2087204","volume":"2016","author":"R Thapa","year":"2016","unstructured":"Thapa R, Wilson GD (2016) The importance of CD44 as a stem cell biomarker and therapeutic target in cancer. Stem Cells Int 2016:2087204","journal-title":"Stem Cells Int"},{"key":"501_CR95","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G et al (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:189\u2013196","journal-title":"Science"},{"key":"501_CR96","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc3495","volume":"13","author":"SV Torti","year":"2013","unstructured":"Torti SV, Torti FM (2013) Iron and cancer: more ore to be mined. Nat Rev Cancer 13:342\u2013355","journal-title":"Nat Rev Cancer"},{"key":"501_CR97","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, Lennon NJ, Livak KJ, Mikkelsen TS, Rinn JL (2014) The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 32:381\u2013386","journal-title":"Nat Biotechnol"},{"key":"501_CR98","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X et al (2018) Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33:890\u2013904.e5","journal-title":"Cancer Cell"},{"key":"501_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00244-6","volume":"7","author":"LT Vahdat","year":"2021","unstructured":"Vahdat LT, Schmid P, Forero-Torres A, Blackwell K, Telli ML, Melisko M, M\u00f6bus V, Cortes J, Montero AJ, Ma C et al (2021) Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (\u201cMETRIC\u201d): a randomized multicenter study. NPJ Breast Cancer 7:57","journal-title":"NPJ Breast Cancer"},{"key":"501_CR100","doi-asserted-by":"crossref","unstructured":"van Velthoven CTJ, Rando TA (2019) Stem cell quiescence: dynamism, restraint, and cellular idling. Cell Stem Cell 24:213\u2013225","DOI":"10.1016\/j.stem.2019.01.001"},{"key":"501_CR101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1158\/2159-8290.CD-13-0631","volume":"4","author":"N Wagle","year":"2014","unstructured":"Wagle N, Van Allen EM, Treacy DJ, Frederick DT, Cooper ZA, Taylor-Weiner A, Rosenberg M, Goetz EM, Sullivan RJ, Farlow DN et al (2014) MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF\/MEK inhibition. Cancer Discov 4:61\u201368","journal-title":"Cancer Discov"},{"key":"501_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s41232-022-00220-y","volume":"42","author":"W Wang","year":"2022","unstructured":"Wang W, Tabu K, Aimaitijiang A, Taga T (2022) Therapy-resistant nature of cancer stem cells in view of iron metabolism. Inflamm Regen 42:34","journal-title":"Inflamm Regen"},{"key":"501_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2018.00097","volume":"6","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao K, Hackert T, Z\u00f6ller M (2018) CD44\/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression. Front Cell Dev Biol 6:1\u201328","journal-title":"Front Cell Dev Biol"},{"key":"501_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2022.1026278","volume":"12","author":"Y Wei","year":"2022","unstructured":"Wei Y, Li Y, Chen Y, Liu P, Huang S, Zhang Y, Sun Y, Wu Z, Hu M, Wu Q et al (2022) ALDH1: a potential therapeutic target for cancer stem cells in solid tumors. Front Oncol 12:1\u201314","journal-title":"Front Oncol"},{"key":"501_CR105","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1038\/jid.2013.115","volume":"133","author":"DS Widmer","year":"2013","unstructured":"Widmer DS, Hoek KS, Cheng PF, Eichhoff OM, Biedermann T, Raaijmakers MIG, Hemmi S, Dummer R, Levesque MP (2013) Hypoxia contributes to melanoma heterogeneity by triggering HIF1\u03b1-dependent phenotype switching. J Investig Dermatol 133:2436\u20132443","journal-title":"J Investig Dermatol"},{"key":"501_CR106","doi-asserted-by":"crossref","unstructured":"Wouters J, Kalender-Atak Z, Minnoye L, Spanier KI, Waegeneer M De, Gonz\u00e1lez-Blas CB, Mauduit D, Davie K, Hulselmans G, Najem A et al (2020) Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma. Nature Cell Biology 22:986\u2013998","DOI":"10.1038\/s41556-020-0547-3"},{"key":"501_CR107","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G (2024) Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther 9:55","journal-title":"Signal Transduct Target Ther"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00501-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-025-00501-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00501-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:44:33Z","timestamp":1779122673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-025-00501-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":107,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8,7]]}},"alternative-id":["501"],"URL":"https:\/\/doi.org\/10.1038\/s44319-025-00501-w","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}